Immunization against Babesiosis using purified merozoite surface antigens of Basesia bigemina
AssigneeWashington State University Research Foundation
InventorsTravis McGuire, Terry McElwain, Lance Perryman, William Davis
Life of this patent
Estimating the term…
Abstract
Antigenic surface proteins from the intraerythrocytic merozoite stage of Babesia bigemina have been isolated using cell fusions and monoclonal antibodies produced thereby. Immunization of mammals, such as bovines, with purified isolates induces an immunological response that is effective to reduce pathological effects of babesiosis induced by Babesia bigemina. Diagnostic kits using monoclonal antibodies and antigenic surface proteins of Babesia bigemina are also disclosed.
Claims11
A method of treating a bovid to reduce the severity of babesiosis caused by Babesia bigemina consisting essentially of inoculating the bovid with a substantially purified Babesia bigemina protein immunogen selected from the group consisting of the merozoite surface proteins with the approximate molecular weights of 58,000, 55,000 and 45,000 Da.
The method, according to claim 44 or claim 2, wherein said Babesia bigemina protein has an approximate molecular weight of 58,000 Da.
The method, according to claim 44 or claim 2, wherein said Babesia bigemina protein has an approximate molecular weight of 55,000 Da.
The method, according to claim 44 or claim 2, wherein said Babesia bigemina protein has an approximate molecular weight of 45,000 Da.
A composition consisting essentially of at least one immunogenic substantially pure protein of Babesia bigemina, which when inoculated into a bovid is capable of inducing an immune response in said bovid which reduces the severity of babesiosis caused by Babesia bigemina wherein said immunogenic protein is selected from the group consisting of proteins having approximate molecular weights of 58,000, 55,000, and 45,000 Da.
Dependencies are inferred from the claim text.